Literature DB >> 14624781

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.

A Giatromanolaki1, M I Koukourakis, C Simopoulos, A Polychronidis, E Sivridis.   

Abstract

AIM: To investigate the angiogenic and prognostic role of vascular endothelial growth factor (VEGF) in operable gallbladder carcinomas.
METHODS: Sixty patients with early gallbladder carcinomas, treated with surgery alone, were investigated immunohistochemically for the expression of VEGF, thymidine phosphorylase (TP) and new blood vessel formation. The results were correlated with clinico-pathological features and prognosis.
RESULTS: An increased VEGF secretion in gallbladder carcinomas was significantly associated with increased angiogenesis but not with patients survival, although high angiogenesis did relate with poor prognosis. TP was also associated with angiogenesis, but only the combined VEGF/TP expression was associated with unfavourable survival. Histological grade was another independent factor of prognosis.
CONCLUSION: Both VEGF and TP expression are associated with high rate of angiogenesis, a factor directly associated with prognosis. The combined expression of these angiogenic factors confer a particularly poor post-operative outcome, speculature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624781     DOI: 10.1016/j.ejso.2003.09.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis.

Authors:  A Efthimiadou; B Asimakopoulos; N Nikolettos; A Giatromanolaki; E Sivridis; D N Papachristou; E Kontoleon
Journal:  Br J Sports Med       Date:  2006-01       Impact factor: 13.800

2.  Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.

Authors:  Ling-Qiang Zhang; Xin-Sen Xu; Yong Wan; Si-Dong Song; Rui-Tao Wang; Wei Chen; Zhi-Xin Wang; Hu-Lin Chang; Ji-Chao Wei; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  Targeting metastatic upper gastrointestinal adenocarcinomas.

Authors:  Jennifer L Spratlin; Quincy Chu; Sheryl Koski; Karen King; Karen Mulder
Journal:  World J Clin Oncol       Date:  2011-03-10

4.  Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Costantinos Simopoulos; Alexandros Polychronidis; Efthimios Sivridis
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

6.  Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma.

Authors:  Xiao-Nan Sun; Wei-Guo Cao; Xin Wang; Qi Wang; Ben-Xing Gu; Qi-Chu Yang; Jian-Bin Hu; Hai Liu; Shu Zheng
Journal:  Tumour Biol       Date:  2011-08-19

7.  Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.

Authors:  Erdenebulgan Batmunkh; Mitsuo Shimada; Yuji Morine; Satoru Imura; Hirofumi Kanemura; Yusuke Arakawa; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Masaaki Nishi
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

8.  Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase.

Authors:  Yukari Harino; Satoru Imura; Hirofumi Kanemura; Yuji Morine; Masahiko Fujii; Toru Ikegami; Hisanori Uehara; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

9.  The expression of tumstatin is down-regulated in renal carcinoma.

Authors:  Chun-xiao Xu; Xian-xi Liu; Guo-sheng Hou; Yun-fei Yan; Shi-min Chen; Wei Wang; Guang-shui Jiang; Bin Liu; Jia-xuan Xin
Journal:  Mol Biol Rep       Date:  2009-08-18       Impact factor: 2.316

Review 10.  Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.

Authors:  Karen Mulder; Sheryl Koski; Andrew Scarfe; Quincy Chu; Karen King; Jennifer Spratlin
Journal:  Oncotarget       Date:  2010-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.